• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author's Reflections: Extrahepatic Cholangiocarcinoma as an Oncological Consistent Entity: Insights from Proteomic Profiling and Lack of Anatomical Impact.

作者信息

Marichez A, Raymond A A, Saltel F, Chiche L

机构信息

Department of Hepatobiliopancreatic Surgery and Liver Transplantation, Haut-Levêque Hospital, Bordeaux University Hospital, Bordeaux, France.

Bordeaux University, Inserm UMR1312 BoRdeaux Institute of onCology (BRIC), Bordeaux, France.

出版信息

Ann Surg Oncol. 2025 Aug 13. doi: 10.1245/s10434-025-18080-4.

DOI:10.1245/s10434-025-18080-4
PMID:40802084
Abstract
摘要

相似文献

1
ASO Author's Reflections: Extrahepatic Cholangiocarcinoma as an Oncological Consistent Entity: Insights from Proteomic Profiling and Lack of Anatomical Impact.ASO作者反思：肝外胆管癌作为一种肿瘤学上一致的实体：蛋白质组学分析的见解及解剖学影响的缺乏
Ann Surg Oncol. 2025 Aug 13. doi: 10.1245/s10434-025-18080-4.
2
Blurring the Anatomical Lines in Extrahepatic Cholangiocarcinoma: An Integrated Clinic-Oncological and Exploratory Proteomic Comparison of Perihilar and Distal Tumors.肝外胆管癌中解剖学界限的模糊：肝门部和远端肿瘤的临床肿瘤学综合及探索性蛋白质组学比较
Ann Surg Oncol. 2025 Jul 16. doi: 10.1245/s10434-025-17811-x.
3
PTEN deficiency induces an extrahepatic cholangitis-cholangiocarcinoma continuum via aurora kinase A in mice.PTEN 缺失通过小鼠中的极光激酶 A 诱导肝外胆管炎-胆管癌连续病变。
J Hepatol. 2024 Jul;81(1):120-134. doi: 10.1016/j.jhep.2024.02.018. Epub 2024 Feb 28.
4
Hepatopancreatoduodenectomy for Extrahepatic Cholangiocarcinoma: A Series of 100 Consecutive Cases from an Expert Center in Japan.肝胰十二指肠切除术治疗肝外胆管癌：来自日本一个专家中心的100例连续病例系列
Ann Surg Oncol. 2025 May 21. doi: 10.1245/s10434-025-17515-2.
5
Deciphering cholangiocarcinoma heterogeneity and specific progenitor cell niche of extrahepatic cholangiocarcinoma at single-cell resolution.以单细胞分辨率解析肝外胆管癌的胆管癌异质性和特定祖细胞生态位。
J Hematol Oncol. 2025 Jun 23;18(1):66. doi: 10.1186/s13045-025-01716-z.
6
FGFR2-Rearrangement in Intrahepatic and Extrahepatic Cholangiocarcinoma and Prognostic Analysis.肝内和肝外胆管癌中的FGFR2重排及预后分析
Int J Gen Med. 2025 Jun 30;18:3569-3578. doi: 10.2147/IJGM.S526759. eCollection 2025.
7
Proteogenomic profiling predicts outcomes of adjuvant chemotherapy in extrahepatic cholangiocarcinoma.
J Hepatol. 2025 Aug 11. doi: 10.1016/j.jhep.2025.07.031.
8
The diagnostic value of the multiparameter combination diagnostic model based on 2-[F]FDG PET/CT metabolic parameters and clinical variables in distinguishing non-metastatic cholangiocarcinoma from cholangitis.基于2-[F]FDG PET/CT代谢参数和临床变量的多参数组合诊断模型在鉴别非转移性胆管癌与胆管炎中的诊断价值
Quant Imaging Med Surg. 2025 Jul 1;15(7):6147-6159. doi: 10.21037/qims-24-1626. Epub 2025 Jun 30.
9
Is adjuvant radiotherapy needed after curative resection of extrahepatic biliary tract cancers? A systematic review with a meta-analysis of observational studies.根治性切除术后是否需要辅助放疗治疗肝外胆管癌？一项基于观察性研究的系统回顾和荟萃分析。
Cancer Treat Rev. 2012 Apr;38(2):111-9. doi: 10.1016/j.ctrv.2011.05.003. Epub 2011 Jun 8.
10
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma.肝外胆管癌的放化疗与近距离放射治疗
Crit Rev Oncol Hematol. 2014 Apr;90(1):58-67. doi: 10.1016/j.critrevonc.2013.10.007. Epub 2013 Nov 2.

本文引用的文献

1
Blurring the Anatomical Lines in Extrahepatic Cholangiocarcinoma: An Integrated Clinic-Oncological and Exploratory Proteomic Comparison of Perihilar and Distal Tumors.肝外胆管癌中解剖学界限的模糊：肝门部和远端肿瘤的临床肿瘤学综合及探索性蛋白质组学比较
Ann Surg Oncol. 2025 Jul 16. doi: 10.1245/s10434-025-17811-x.
2
Extrahepatic Cholangiocarcinoma: Genomic Variables Associated With Anatomic Location and Outcome.肝外胆管癌：与解剖位置和预后相关的基因组变量。
JCO Precis Oncol. 2024 Jul;8:e2400206. doi: 10.1200/PO.24.00206.
3
Adjuvant gemcitabine plus cisplatin versus capecitabine in node-positive extrahepatic cholangiocarcinoma: the STAMP randomized trial.
辅助吉西他滨加顺铂与卡培他滨治疗淋巴结阳性肝外胆管癌：STAMP 随机试验。
Hepatology. 2023 May 1;77(5):1540-1549. doi: 10.1097/HEP.0000000000000046. Epub 2023 Jan 3.
4
Proteomic Profiling of Hepatocellular Adenomas Paves the Way to Diagnostic and Prognostic Approaches.肝细胞腺瘤的蛋白质组学分析为诊断和预后方法铺平了道路。
Hepatology. 2021 Sep;74(3):1595-1610. doi: 10.1002/hep.31826. Epub 2021 Jul 13.
5
Time to Recurrence After Surgical Resection and Survival After Recurrence Among Patients with Perihilar and Distal Cholangiocarcinomas.肝门部和远端胆管癌患者手术切除后的复发时间和复发后的生存时间。
Ann Surg Oncol. 2020 Oct;27(11):4171-4180. doi: 10.1245/s10434-020-08534-2. Epub 2020 May 3.
6
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma.肝外胆管癌的分子分类与治疗靶点
J Hepatol. 2020 Aug;73(2):315-327. doi: 10.1016/j.jhep.2020.03.008. Epub 2020 Mar 12.
7
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.卡培他滨对比观察用于可切除胆管癌（BILCAP）：一项随机、对照、多中心、3 期研究。
Lancet Oncol. 2019 May;20(5):663-673. doi: 10.1016/S1470-2045(18)30915-X. Epub 2019 Mar 25.